Sippican Capital Advisors Grows Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Sippican Capital Advisors boosted its position in Select Medical Holdings Co. (NYSE:SEM) by 7.3% in the 4th quarter, Holdings Channel reports. The firm owned 13,354 shares of the health services provider’s stock after acquiring an additional 912 shares during the quarter. Sippican Capital Advisors’ holdings in Select Medical were worth $252,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Geode Capital Management LLC grew its holdings in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after buying an additional 46,880 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Select Medical by 6.7% in the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after purchasing an additional 147,032 shares during the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after buying an additional 1,216,263 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of Select Medical by 1.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its position in Select Medical by 0.6% in the 3rd quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after buying an additional 7,372 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Trading Down 3.6 %

NYSE SEM opened at $19.64 on Thursday. The firm’s fifty day moving average is $20.61 and its two-hundred day moving average is $30.16. Select Medical Holdings Co. has a one year low of $18.02 and a one year high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The firm has a market cap of $2.54 billion, a PE ratio of 9.18, a P/E/G ratio of 0.65 and a beta of 1.45.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business earned $0.46 EPS. Analysts expect that Select Medical Holdings Co. will post 1.97 earnings per share for the current year.

Insider Buying and Selling at Select Medical

In other news, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

SEM has been the topic of a number of recent research reports. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Monday. Finally, UBS Group dropped their price target on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, Select Medical currently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.